Showing results (101-110 of 261) with videos related to
Sort By:
Pageof 27
American Journal of Hematology|April 5, 2012
Does iron overload really matter in stem cell transplantation?Philippe Armand, Marie-Michele Sainvil, Haesook T Kim, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysisPhilippe Armand, Haesook T Kim, Johanna M Virtanen, et al.British Journal of Haematology|January 3, 2013
Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography eraPhilippe Armand, Sarah Welch, Haesook T Kim, et al.Blood Advances|March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W Merryman, Robert A Redd, Taiga Nishihori, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F Herrera, Matthew Mei, Lawrence Low, et al.JCI Insight|June 3, 2020
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapyPei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 14, 2011
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphomaGregory M Cote, Ephraim P Hochberg, Alona Muzikansky, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2018
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell TransplantationLindsey E Roeker, Haesook T Kim, Brett Glotzbecker, et al.Haematologica|January 16, 2016
Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantationPaul S Martin, Shuli Li, Sarah Nikiforow, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2012
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysisJoshua A Hill, Sophia Koo, Belisa B Guzman Suarez, et al.Pageof 27